注射用抗凝固剤の世界市場2020-2026:低分子ヘパリン(LMWH)、直接トロンビン阻害剤(DTI)、その他

QYResearchが発行した調査報告書(QYR20AP01120)
◆英語タイトル:Global Injectable Anticoagulants Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP01120
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、注射用抗凝固剤の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、注射用抗凝固剤のグローバル市場動向、メーカー別競争状況、種類別市場規模(低分子ヘパリン(LMWH)、直接トロンビン阻害剤(DTI)、その他)、用途別市場規模(VTE、ACS/MI、AF、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・注射用抗凝固剤の種類別市場2015-2026:低分子ヘパリン(LMWH)、直接トロンビン阻害剤(DTI)、その他
・注射用抗凝固剤の用途別市場2015-2026:VTE、ACS/MI、AF、その他
・注射用抗凝固剤の北米市場分析
・注射用抗凝固剤のアジア市場分析
・注射用抗凝固剤の中南米市場分析
・注射用抗凝固剤の中東・アフリカ市場分析
・関連企業情報:Sanofi、Genentech (Roche)、Boehringer Ingelheim、Pfizer、The Medicines Company、Aspen、Otsuka
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
In 2019, the global Injectable Anticoagulants market size was US$ 5814.9 million and is forecast to US$ 7070.3 million in 2026, growing at a CAGR of 2.8% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Injectable Anticoagulants.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Injectable Anticoagulants market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Injectable Anticoagulants market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Injectable Anticoagulants market. Readers of the report can become informed about current and future trends of the global Injectable Anticoagulants market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Injectable Anticoagulants markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Injectable Anticoagulants market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Injectable Anticoagulants market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Injectable Anticoagulants market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Injectable Anticoagulants market is segmented into
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other

Market Segment by Application, the Injectable Anticoagulants market is segmented into
VTE
ACS/MI
AF
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka

The study objectives are:
To analyze and research the global Injectable Anticoagulants status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Injectable Anticoagulants manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Injectable Anticoagulants are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Injectable Anticoagulants Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Injectable Anticoagulants Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Low-molecular-weight Heparin (LMWH)
1.3.3 Direct Thrombin Inhibitor (DTI)
1.3.4 Other
1.4 Market Segment by Application
1.4.1 Global Injectable Anticoagulants Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 VTE
1.4.3 ACS/MI
1.4.4 AF
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Injectable Anticoagulants Revenue (2015-2026)
2.1.1 Global Injectable Anticoagulants Revenue (2015-2026)
2.1.2 Global Injectable Anticoagulants Sales (2015-2026)
2.2 Injectable Anticoagulants Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Injectable Anticoagulants Sales by Regions (2015-2020)
2.2.2 Global Injectable Anticoagulants Revenue by Regions (2015-2020)
2.3 Global Top Injectable Anticoagulants Regions (Countries) Ranking by Market Size
2.4 Injectable Anticoagulants Industry Trends
2.4.1 Injectable Anticoagulants Market Top Trends
2.4.2 Market Drivers
2.4.3 Injectable Anticoagulants Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Injectable Anticoagulants Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Injectable Anticoagulants Manufacturers by Sales (2015-2020)
3.1.1 Global Injectable Anticoagulants Sales by Manufacturers (2015-2020)
3.1.2 Global Injectable Anticoagulants Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Injectable Anticoagulants Sales in 2019
3.2 Global Top Manufacturers Injectable Anticoagulants by Revenue
3.2.1 Global Injectable Anticoagulants Revenue by Manufacturers (2015-2020)
3.2.2 Global Injectable Anticoagulants Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Injectable Anticoagulants Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anticoagulants as of 2019)
3.4 Global Injectable Anticoagulants Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Injectable Anticoagulants Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Injectable Anticoagulants Market
3.7 Key Manufacturers Injectable Anticoagulants Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Injectable Anticoagulants Historic Market Review by Type (2015-2020)
4.1.2 Global Injectable Anticoagulants Sales Market Share by Type (2015-2020)
4.1.3 Global Injectable Anticoagulants Revenue Market Share by Type (2015-2020)
4.1.4 Injectable Anticoagulants Price by Type (2015-2020)
4.1 Global Injectable Anticoagulants Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Injectable Anticoagulants Sales Forecast by Type (2021-2026)
4.2.3 Global Injectable Anticoagulants Revenue Forecast by Type (2021-2026)
4.2.4 Injectable Anticoagulants Price Forecast by Type (2021-2026)

5 Global Injectable Anticoagulants Market Size by Application
5.1 Global Injectable Anticoagulants Historic Market Review by Application (2015-2020)
5.1.2 Global Injectable Anticoagulants Sales Market Share by Application (2015-2020)
5.1.3 Global Injectable Anticoagulants Revenue Market Share by Application (2015-2020)
5.1.4 Injectable Anticoagulants Price by Application (2015-2020)
5.2 Global Injectable Anticoagulants Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Injectable Anticoagulants Sales Forecast by Application (2021-2026)
5.2.3 Global Injectable Anticoagulants Revenue Forecast by Application (2021-2026)
5.2.4 Injectable Anticoagulants Price Forecast by Application (2021-2026)

6 North America
6.1 North America Injectable Anticoagulants Breakdown Data by Company
6.2 North America Injectable Anticoagulants Breakdown Data by Type
6.3 North America Injectable Anticoagulants Breakdown Data by Application
6.4 North America Injectable Anticoagulants Breakdown Data by Countries
6.4.1 North America Injectable Anticoagulants Sales by Countries
6.4.2 North America Injectable Anticoagulants Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Injectable Anticoagulants Breakdown Data by Company
7.2 Europe Injectable Anticoagulants Breakdown Data by Type
7.3 Europe Injectable Anticoagulants Breakdown Data by Application
7.4 Europe Injectable Anticoagulants Breakdown Data by Countries
7.4.1 Europe Injectable Anticoagulants Sales by Countries
7.4.2 Europe Injectable Anticoagulants Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Injectable Anticoagulants Breakdown Data by Company
8.2 Asia Pacific Injectable Anticoagulants Breakdown Data by Type
8.3 Asia Pacific Injectable Anticoagulants Breakdown Data by Application
8.4 Asia Pacific Injectable Anticoagulants Breakdown Data by Regions
8.4.1 Asia Pacific Injectable Anticoagulants Sales by Regions
8.4.2 Asia Pacific Injectable Anticoagulants Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Injectable Anticoagulants Breakdown Data by Company
9.2 Latin America Injectable Anticoagulants Breakdown Data by Type
9.3 Latin America Injectable Anticoagulants Breakdown Data by Application
9.4 Latin America Injectable Anticoagulants Breakdown Data by Countries
9.4.1 Latin America Injectable Anticoagulants Sales by Countries
9.4.2 Latin America Injectable Anticoagulants Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Injectable Anticoagulants Breakdown Data by Type
10.2 Middle East and Africa Injectable Anticoagulants Breakdown Data by Application
10.3 Middle East and Africa Injectable Anticoagulants Breakdown Data by Countries
10.3.1 Middle East and Africa Injectable Anticoagulants Sales by Countries
10.3.2 Middle East and Africa Injectable Anticoagulants Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Sanofi Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Sanofi Injectable Anticoagulants Products and Services
11.1.5 Sanofi SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Corporation Information
11.2.2 Genentech (Roche) Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Genentech (Roche) Injectable Anticoagulants Products and Services
11.2.5 Genentech (Roche) SWOT Analysis
11.2.6 Genentech (Roche) Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Injectable Anticoagulants Products and Services
11.3.5 Boehringer Ingelheim SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Pfizer Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Pfizer Injectable Anticoagulants Products and Services
11.4.5 Pfizer SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 The Medicines Company
11.5.1 The Medicines Company Corporation Information
11.5.2 The Medicines Company Business Overview and Total Revenue (2019 VS 2018)
11.5.3 The Medicines Company Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 The Medicines Company Injectable Anticoagulants Products and Services
11.5.5 The Medicines Company SWOT Analysis
11.5.6 The Medicines Company Recent Developments
11.6 Aspen
11.6.1 Aspen Corporation Information
11.6.2 Aspen Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Aspen Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Aspen Injectable Anticoagulants Products and Services
11.6.5 Aspen SWOT Analysis
11.6.6 Aspen Recent Developments
11.7 Otsuka
11.7.1 Otsuka Corporation Information
11.7.2 Otsuka Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Otsuka Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Otsuka Injectable Anticoagulants Products and Services
11.7.5 Otsuka SWOT Analysis
11.7.6 Otsuka Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Injectable Anticoagulants Sales Channels
12.2.2 Injectable Anticoagulants Distributors
12.3 Injectable Anticoagulants Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Injectable Anticoagulants Sales Forecast (2021-2026)
13.1.1 Global Injectable Anticoagulants Sales Forecast by Regions (2021-2026)
13.1.2 Global Injectable Anticoagulants Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Injectable Anticoagulants Sales Forecast (2021-2026)
13.2.2 North America Injectable Anticoagulants Revenue Forecast (2021-2026)
13.2.3 North America Injectable Anticoagulants Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Injectable Anticoagulants Sales Forecast (2021-2026)
13.3.2 Europe Injectable Anticoagulants Revenue Forecast (2021-2026)
13.3.3 Europe Injectable Anticoagulants Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Injectable Anticoagulants Sales Forecast (2021-2026)
13.4.2 Asia Pacific Injectable Anticoagulants Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Injectable Anticoagulants Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Injectable Anticoagulants Sales Forecast (2021-2026)
13.5.2 Latin America Injectable Anticoagulants Revenue Forecast (2021-2026)
13.5.3 Latin America Injectable Anticoagulants Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Injectable Anticoagulants Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Injectable Anticoagulants Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Injectable Anticoagulants Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Sanofi、Genentech (Roche)、Boehringer Ingelheim、Pfizer、The Medicines Company、Aspen、Otsuka

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 注射用抗凝固剤の世界市場2020-2026:低分子ヘパリン(LMWH)、直接トロンビン阻害剤(DTI)、その他(Global Injectable Anticoagulants Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。